MB, R., TD, C., L, d. Z., D, R., ME, D., KS, T., . . . N, H. (2025). Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective. Clinical pharmacology and therapeutics, 117(2), 403. https://doi.org/10.1002/cpt.3477
Chicago Style (17th ed.) CitationMB, Reddy, et al. "Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective." Clinical Pharmacology and Therapeutics 117, no. 2 (2025): 403. https://doi.org/10.1002/cpt.3477.
MLA (9th ed.) CitationMB, Reddy, et al. "Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective." Clinical Pharmacology and Therapeutics, vol. 117, no. 2, 2025, p. 403, https://doi.org/10.1002/cpt.3477.